Skip to content

Certipharm

Active Private limited companyfounded 2020active for 6 yearsMolenbaan 50, 2290 VorselaarKBO/BCE: BE 0754.702.164

Annual accounts 2025

micro format, filed on 14-08-2026, 14 days late
€124,569
▲ 45.5%
€123,264
▲ 46.4%
€91,689
▲ 55.1%
€101,015
▲ 69.3%
65.3%
▼ 28.3 percentage points
2.85
▼ 12.47

Turnover is estimated at about €190,000, probably between €150,000 and €260,000. The micro format does not state turnover.

Balance sheet

balance sheet total €157,372 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

65.3%

Higher than 64% of the 10,299 companies filing micro accounts in office administrative support (NACE 82) in 2025.

2.85

Higher than 64% of the 9,879 companies filing micro accounts in office administrative support (NACE 82) in 2025.

58.3%

Higher than 92% of the 10,021 companies filing micro accounts in office administrative support (NACE 82) in 2025.

Certipharm Middle half of the sector 80% of the sector Micro accounts in office administrative support (NACE 82)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202115 months
123,79384,706138,920105,198150,579
92,21759,633109,54684,732118,328
869002,64417,000
89,636-223,66480,11177,949-
101,01559,666293,962185,416103,328
65.3%93.6%93.2%91.2%83.7%
2.8515.3214.6410.955.60
0.530.070.070.100.19
89.2%96.7%35.3%40.0%98.3%
58.3%90.6%32.9%36.5%82.3%
over 100over 100over 100over 100over 100

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202115 months
Balance sheet: assets
20/58 157,37265,270317,485211,223138,033
21/28 1,7781,4381,9667,16412,225
22/27 1,7781,4381,9667,16412,225
24 1,7781,4381,9667,16412,225
29/58 155,59463,833315,519204,059125,808
40/41 18,98315,56044,11212,55213,229
40 18,98315,56044,1127,95013,229
41 --04,602-
54/58 136,61246,976270,640190,528112,579
490/1 -1,297767978-
Balance sheet: equity and liabilities
10/49 157,37265,270317,485211,223138,033
10/15 102,79361,104295,929192,580115,552
10/11 2,0002,0002,0002,0002,000
13 100,79359,104293,929190,580113,552
133 100,79359,104293,929190,580113,552
14 --0--
17/49 54,5804,16621,55718,64322,481
42/48 54,5804,16621,55718,64322,481
44 127-4872,2541,308
440/4 127-4872,2541,308
45 3,5933,98719,64715,87520,508
450/3 3,5933,98719,64715,87520,508
47/48 50,8591791,422514665
Income statement
9900 124,56985,612139,092105,362150,680
630 5295295,1987,7044,775
640/8 776906172164101
9901 123,26484,177133,72297,494145,804
75/76B 0----
75 0----
65/66B 7073696974
65 7073696974
9903 123,19484,104133,65397,425145,730
67/77 31,50525,00029,30520,39732,177
9904 91,68959,104104,34877,028113,552
9905 91,68959,104104,34877,028113,552
Appropriation of the result
9906 91,68959,104104,34877,028113,552
791/2 -293,929---
691/2 41,68959,104103,34877,028113,552
6921 41,68959,104103,34877,028113,552
694/7 50,000293,9291,000--
694 50,000293,9291,000--
Document PDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 14-08-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 14-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00398573.

Financial year Type Filed Reference Document
31-12-2025 micro format 14-08-2026 2026-00398573 PDF
31-12-2024 micro format 18-08-2025 2025-00380279 PDF
31-12-2023 micro format 26-02-2024 2024-00035445 PDF
31-12-2022 micro format 31-07-2023 2023-00293397 PDF
31-12-2021 micro format 26-07-2022 2022-20221121 PDF

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€869--€2,644€17,000
€529€529€5,198€7,704€4,775

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on Certipharm

The operating result for 2025 is 46% higher than in 2024. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total rises from 6.4% to 34.7%. Equity and debt are higher.

Next steps